DEAR VISITORS, THE NEW WEBSITE IS UNDER CONSTRUCTION, SO WE ASK FOR YOUR UNDERSTANDING IF YOU ENCOUNTER OUT-OF-DATE OR INCORRECT INFORMATION. FOR ALL QUESTIONS, WE ARE AT YOUR DISPOSAL BY PHONE +38131597597 or e-mail address: office@cigota.rs
Srpski
English
Русский
Case Series of Dermopathy in Autoimmune Thyroid Disease
English
Clinical Center of Endocrinology, Diabetes, and Metabolic Diseases, University Clinical Center of Serbia, Department of Thyroid Diseases
Medical Faculty, University of Belgrade, Serbia
Fatourechi V, Bartley GB, Eghbali-Fatourechi GZ, Powell CC, Ahmed DD, Garrity JA. Graves’ dermopathy and acropachy are markers of severe Graves’ ophthalmopathy. Thyroid. 2003 Dec;13(12):1141-4.
Fatourechi V, Garrity JA, Bartley GB, Bergstralh EJ, Gorman CA. Orbital decompression in Graves’ ophthalmopathy associated with pretibial myxedema. J Endocrinol Invest. 1993 Jun;16(6):433-7.
Fatourechi V, Pajouhi M, Fransway AF. Dermopathy of Grave’s disease (pretibial myxe- dema). Review of 150 cases. Medicine (Baltimore). 1994; 73:1-7;
Case Series of Dermopathy in Autoimmune Thyroid Disease
Steroid-Resistant Graves’ Orbitopathy – therapeutic options
English
Clinic of Endocrinology, Diabetes and Metabolic Disease, University Clinical Center of Serbia
Faculty of medicine, University of Belgrade
Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML. Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy. Front Endocrinol (Lausanne). 2020; 11: 1.
Men CJ, Kossler AL, Wester ST. Updates on the understanding and management of thyroid eye disease. Ther Adv Ophthalmol 2021; 13: 1–14. Kortokorezistentna Grejvsova orbitopatija – terapijske opcije 83
Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinha Hikim A, Gianoukakis AG, Douglas RS, Smith TJ. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves’ dis
Steroid-Resistant Graves’ Orbitopathy – therapeutic options
Aggressive clinical course of medullary thyroid microcarcinoma
English
Clinic of Endocrinology, Diabetes and Metabolic Disease, University Clinical Center of Serbia
Faculty of medicine, University of Belgrade
Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. US and German Thyroid Cancer Study Group An American College of Surgeons Commission on C
Perry A, Molberg K, Albores-Saavedra J. Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities. Cancer 1996; 77: 750–756.
Albores-Saavedra, J., Krueger, J. E. C-Cell hyperplasia and medullary thyroid microcarcinoma. Endocr Pathol 12, 365–377 (2001). https://doi.org/10.1385/EP:12:4:365
Aggressive clinical course of medullary thyroid microcarcinoma
Image-guided methods in the treatment of thyroid nodules and cancer
English
Clinic of Endocrinology, Diabetes and Metabolic Disease, University Clinical Center of Serbia.
Faculty of Medicine, University of Belgrade
Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med. 1994 Aug 22; 154(16): 1838–40.
Mazzaferri EL. Management of a Solitary Thyroid Nodule. New England Journal of Medicine. 1993 Feb 25; 328(8): 553–9.
Ahn HS, Kim HJ, Welch HG. Korea’s Thyroid-Cancer “Epidemic” — Screening and Overdiagnosis. New England Journal of Medicine. 2014 Nov 6; 371(19): 1765–7.
Image-guided methods in the treatment of thyroid nodules and cancer
CONTACT US